Oral cancer prevention and the evolution of molecular-targeted drug development.
about
Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicantsQuercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cellsAnalysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats.Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO.Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesionsSalvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathwaysCombination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.Salivary proteomics for oral cancer biomarker discoveryA DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.Overexpression of lecithin:retinol acyltransferase in the epithelial basal layer makes mice more sensitive to oral cavity carcinogenesis induced by a carcinogen.Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice.Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties.Retinoid pathway and cancer therapeuticsNear infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxideSalvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.Quality of life following surgical treatment of oral cancersFunctions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.O2 and Ca(2+) fluxes as indicators of apoptosis induced by rose bengal-mediated photodynamic therapy in human oral squamous carcinoma cells.Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols.The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cells.Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles.Oral premalignancy: new methods of detection and treatmentGene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technologyClinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosisA minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasiaTopical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic LesionsBasal stem cells contribute to squamous cell carcinomas in the oral cavity.Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling.Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanate.Effects of 1,4-phenylenebis(methylene)selenocyanate on mutagenesis and p53 protein expression in the tongue of lacI rats treated with 4-nitroquinoline-N-oxide.ASC contributes to metastasis of oral cavity squamous cell carcinomaInterleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.Relationship between head and neck cancer therapy and some genetic endpointsMiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1.
P2860
Q28078495-3F65123A-542C-4821-812C-D0109515B487Q28485142-7BBA9F47-D7AD-4878-8001-D5F19AA2F5A3Q30872573-C9030AB2-6D4A-49AE-A118-C8DC44827FF3Q33276933-813F5070-8518-4582-B208-ACA99BCA80FCQ33328405-55CAF6AF-E23C-43C5-83AE-4E05D00DC40CQ33769748-FA1584B1-257C-4076-BB3D-3919B52ADF04Q33789889-FEEEF249-C5E4-492D-B172-3E89425A8487Q33879157-3A889A85-99BE-4585-899E-E3778CC99175Q33880963-5258F453-7651-4A0E-9643-396F34318CE5Q33901872-B8B76BCD-D96D-4A21-834C-7C8E8AA78F4DQ34138632-546AD41C-49ED-46B3-87AA-9F090F91F46DQ34168436-2E179197-E8C8-44DF-BB44-B0F34071203DQ34348117-C0E777D0-5829-4988-BB5C-3B5BF737E485Q34430979-4359E7C9-198B-4ACA-AEC9-9F7FDACFF6D8Q34442838-30FC07CE-0778-47DF-9509-2DCA5DF868A9Q35139472-9F0F9BB4-ACF6-4E3B-A120-BB28F35726D7Q35575766-0A2C3DD4-B58F-4DAC-A9DE-CD20DE280657Q35625066-FB2830C5-ED80-4D7C-90BB-44682C3F0DE6Q36061785-42331E29-90A9-446B-BF7C-648CEF0E7BD6Q36082444-C7CCD578-C78D-4EC1-A5B5-6720509C82EDQ36154748-695DF886-9DDC-4527-A74B-9D22E4D6AC56Q36250099-FDC68413-A4C5-47E5-9301-E25CD813A910Q36409243-B62E3626-0066-44D2-AF2C-7C1EA6A1E425Q36414478-4B0C8538-B0D3-489F-890B-65033CA10825Q36489312-CE5CCBAF-72D1-48FE-8238-EEE0DF732355Q36613980-0E9769F7-0B78-4457-8742-0530B28B79BFQ36614077-27CB44EC-CE2B-47B8-85EA-E307EBE61743Q36778434-15A3CA98-EB28-48BF-A973-34EBF50141D6Q36813991-3F400DAA-EC0F-45CE-A56D-DCD115A04DABQ36887378-78A15736-8B6E-43FE-9C2F-CC2F522A2614Q36957747-E8D36F00-343E-4EEB-98E1-15B3FCB77E78Q37039386-84A260DE-257F-4CA8-BA44-E553CE1178CFQ37086148-A061544E-2065-4713-9C2C-46DDD0B568F2Q37200462-87049D48-92AA-4B28-B8EA-D90FD65DA876Q37221333-12D353B2-C66E-49DC-9C69-CC51BF426DAFQ37236811-DD1346B0-5F53-42FE-A64C-9DC715921E02Q37580367-D6E99D8F-BAD9-4A78-A980-A78189E8A41AQ37701659-010DF6C0-2518-4189-B2DB-0BB5896BE2E8Q38211868-C4C79357-09E2-4BA1-9C0C-AC8D5AFD7976Q38301327-492E008D-2720-4B9B-8E17-D0FAE54DB847
P2860
Oral cancer prevention and the evolution of molecular-targeted drug development.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Oral cancer prevention and the evolution of molecular-targeted drug development.
@ast
Oral cancer prevention and the evolution of molecular-targeted drug development.
@en
type
label
Oral cancer prevention and the evolution of molecular-targeted drug development.
@ast
Oral cancer prevention and the evolution of molecular-targeted drug development.
@en
prefLabel
Oral cancer prevention and the evolution of molecular-targeted drug development.
@ast
Oral cancer prevention and the evolution of molecular-targeted drug development.
@en
P2093
P356
P1476
Oral cancer prevention and the evolution of molecular-targeted drug development.
@en
P2093
Scott M Lippman
Waun Ki Hong
P304
P356
10.1200/JCO.2005.09.128
P407
P577
2005-01-01T00:00:00Z